CNS Neuroscience & Therapeutics, 2024 · DOI: https://doi.org/10.1111/cns.70130 · Published: October 17, 2024
Spinal cord injury (SCI) often leads to neuroinflammation, where microglia cells in the spinal cord undergo pyroptosis, a form of cell death that worsens the injury. Bmal1, a gene involved in the body's internal clock, might play a role in regulating this process. This study found that Bmal1 can inhibit microglial pyroptosis after SCI by regulating the NF-κB /MMP9 pathway. This pathway involves proteins that control inflammation and tissue breakdown. The research suggests that targeting Bmal1 could be a new way to treat SCI by reducing neuroinflammation and promoting recovery.
Bmal1 may be considered as a new target for the treatment of SCI.
NF-κB/MMP9 signaling pathway is involved in regulating microglial pyroptosis after Bmal1-inhibited SCI in vivo.
Bmal1 can alleviate spinal cord injury by reducing microglial pyroptosis.